You are here

  • Home
  • Archive
  • Volume 74, Issue 1
  • Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis

Article info

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Free

Authors

  • Alper M van Sijl Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Internal Medicine, Institute for Cardiovascular Research (ICAR), VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Izhar C van Eijk Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Mike J L Peters Department of Internal Medicine, Institute for Cardiovascular Research (ICAR), VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Erik H Serné Department of Internal Medicine, Institute for Cardiovascular Research (ICAR), VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Irene E van der Horst-Bruinsma Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Yvo M Smulders Department of Internal Medicine, Institute for Cardiovascular Research (ICAR), VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Michael T Nurmohamed Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Internal Medicine, Institute for Cardiovascular Research (ICAR), VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Alper M van Sijl, Department of Rheumatology, Jan van Breemen Research Institute Reade, Jan van Breemenstraat 2, PO Box 58271, 1040| HG, Amsterdam, The Netherlands; a.v.sijl{at}reade.nl
View Full Text

Citation

van Sijl AM, van Eijk IC, Peters MJL, et al
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Annals of the Rheumatic Diseases 2015;74:119-123.

Publication history

  • Received May 12, 2013
  • Revised August 8, 2013
  • Accepted September 19, 2013
  • First published October 3, 2013.
Online issue publication 
April 06, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions